(DBXN) Xtrackers II Eurozone - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0290355717

DBXN: Eurozone, Government, Bond

The Xtrackers II Eurozone Government Bond UCITS ETF1C EUR is an exchange-traded fund listed on XETRA, tracking the Morningstar Eurozone Treasury Bond Gross Return EUR Index. It provides investors with exposure to a diversified portfolio of Eurozone government bonds.

As a EUR Government Bond ETF, it is designed to capture the returns of the Eurozone government bond market, offering a relatively stable investment option for those seeking to manage interest rate risk or diversify their portfolios. The fund is managed by DWS, a reputable asset management firm, and is domiciled in Germany.

Analyzing the funds recent price action, we observe a steady upward trend, with the last price recorded at 223.27 EUR. The short-term (SMA20) and medium-term (SMA50) moving averages are 222.00 EUR and 221.29 EUR, respectively, indicating a positive momentum. The long-term trend (SMA200) is also upward, at 220.46 EUR. The Average True Range (ATR) is 0.89 EUR, or 0.40%, suggesting relatively low volatility.

With Assets Under Management (AUM) of 2131.20M EUR, the fund demonstrates a significant presence in the market, indicating liquidity and investor confidence. This substantial AUM also implies that the fund is well-established and has a broad investor base.

Forecasting future performance based on the available technical and fundamental data, we can anticipate a continued upward trend in the short to medium term, driven by the positive momentum indicated by the moving averages. However, the relatively low volatility, as measured by ATR, may limit the potential for significant price movements. The Eurozone government bond market is likely to be influenced by ECB monetary policy decisions and economic indicators. Assuming a stable economic environment and continued accommodative monetary policy, we can expect the fund to maintain its current trajectory, potentially reaching the 52-week high of 224.85 EUR. Conversely, any unexpected economic downturn or change in monetary policy stance could lead to increased volatility and potential price corrections.

Additional Sources for DBXN ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

DBXN ETF Overview

Market Cap in USD 2,499m
Category EUR Government Bond
TER 0.11%
IPO / Inception 2007-05-22

DBXN ETF Ratings

Growth Rating -18.4
Fundamental -
Dividend Rating 0.10
Rel. Strength 2.72
Analysts -
Fair Price Momentum 204.03 EUR
Fair Price DCF -

DBXN Dividends

Currently no dividends paid

DBXN Growth Ratios

Growth Correlation 3m 70.8%
Growth Correlation 12m 49.3%
Growth Correlation 5y -62.5%
CAGR 5y -2.40%
CAGR/Max DD 5y -0.11
Sharpe Ratio 12m 0.07
Alpha -0.03
Beta 0.005
Volatility 4.48%
Current Volume 7k
Average Volume 20d 3.2k
What is the price of DBXN shares?
As of July 01, 2025, the stock is trading at EUR 222.01 with a total of 7,001 shares traded.
Over the past week, the price has changed by -0.30%, over one month by -0.22%, over three months by +1.82% and over the past year by +4.75%.
Is Xtrackers II Eurozone a good stock to buy?
Neither. Based on ValueRay´s Analyses, Xtrackers II Eurozone is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -18.38 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DBXN is around 204.03 EUR . This means that DBXN is currently overvalued and has a potential downside of -8.1%.
Is DBXN a buy, sell or hold?
Xtrackers II Eurozone has no consensus analysts rating.
What are the forecasts for DBXN share price target?
According to our own proprietary Forecast Model, DBXN Xtrackers II Eurozone will be worth about 220.4 in July 2026. The stock is currently trading at 222.01. This means that the stock has a potential downside of -0.74%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 220.4 -0.7%